Biggest News Aggregation in the World
📰 Elsevier News

Page 17 - Elsevier News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Elsevier. Real-time updates on events, politics, business and more.

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

While reinforcing the importance of treating all known risk factors that contribute to atherosclerotic cardiovascular disease, ASCVD, physicians also need to recognize and treat systemic inflammation in CV disease, according to Dr. Quigley, who addresses the importance of identifying and reducing residual inflammatory risk.
United States Robertl Quigley Acta Pharmacologica Sinica Coll Cardiol A Report From The American Heart Association Jefferson Health System Phil

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

A New 3D Bioprinted Model Offers Novel Tool to Study Common Liver Disease and Perhaps Find an Effective Treatment

Metabolic dysfunction-associated steatohepatitis, or MASH, is an inflammatory, liver-scarring disease that has reached epidemic proportions, with an estimated 1.5% to 6.5% of U.S. adults afflicted by the condition, and roughly 24% of adults having nonalcoholic fatty liver disease (NAFLD). MASH, previously known as nonalcoholic steatohepatitis or NASH, is a more serious complication of NAFLD, now called metabolic dysfunction-associated steatotic liver disease or MASLD. The nomenclature(op...
United States La Jolla San Diego Salk Institute Sara Linker Sanford Burnham Prebys

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science